Skip to content
Select language:
  • English (EN)
  • Español (ES)
Donate Fundraise
MS International
  • About MS

    About MS

    • What is MS?

      What is MS?

      • Types of MS
      • Causes of MS
      • MS in Children
    • Diagnosing MS
    • Treatments and therapies

      Treatments and therapies

      • Rehabilitation
      • Complementary therapies 
    • Symptoms of MS

      Symptoms of MS

      • Pain
      • Vision
      • Bladder and bowel
      • Fatigue
      • Emotion and cognitition
      • Sexual problems
      • Movement and coordination
  • Living with MS

    Living with MS

    • Find MS support near you
    • What influences quality of life?
    • Keeping healthy
    • MS and menopause
    • Smoking and MS
    • Relationships

      Relationships

      • Family life
      • Intimacy
      • Caregivers
    • Telling people you have MS
    • Ageing and MS
    • Education and employment
    • COVID-19 advice
  • Research

    Research

    • Atlas of MS
    • Key topics in MS research

      Key topics in MS research

      • Clinical research and trials
      • Epstein-Barr virus and MS
      • MS registries
      • Patient Reported Outcomes for MS
      • Quality of life research in MS
      • Stem cell therapy for MS
    • Awards, grants and fellowships

      Awards, grants and fellowships

      • McDonald Fellowships
      • Du Pré Grants
      • Charcot Award
      • Global MS research fellowships
      • Young Investigator Award
    • Progressive MS Alliance

      Progressive MS Alliance

      • Catch-up on Alliance webcasts
  • Access & advocacy

    Access & advocacy

    • Improve access to MS treatment
    • Improve MS diagnosis
    • Getting the healthcare I need
    • Get the evidence
    • How to get started in advocacy
    • Learn from others
    • MSIF work on access
  • Resources
  • News & events
  • About us

    About us

    • Who we are and what we do
    • Our strategy
    • Our members
    • Our staff
    • How we are governed

      How we are governed

      • Board of trustees
      • Committees and expert groups
    • How we are funded

      How we are funded

      • Our income in 2024
      • How we work with the healthcare industry
      • MSIF COVID-19 Response Initiative
      • Our supporter promise
    • Annual accounts
    • Conflict’s impact on people affected by MS
  • Get involved

    Get involved

    • Contact us
    • Fundraise for MSIF
    • Join MSIF (MS organisations)
    • Sign up for our newsletters
    • World MS Day
    • The May 50K
    • Cycle For MS: Conquer the Tour
  • Get involved
  • Contact us
  • Fundraise for MSIF
  • Join MSIF (MS organisations)
  • Sign up for our newsletters
  • World MS Day
  • The May 50K
  • Cycle For MS: Conquer the Tour
  • How we are funded
  • Our income in 2024
  • How we work with the healthcare industry
  • MSIF COVID-19 Response Initiative
  • Our supporter promise
  • How we are governed
  • Board of trustees
  • Committees and expert groups
  • About us
  • Who we are and what we do
  • Our strategy
  • Our members
  • Our staff
  • How we are governed
  • How we are funded
  • Annual accounts
  • Conflict’s impact on people affected by MS
  • Access & advocacy
  • Improve access to MS treatment
  • Improve MS diagnosis
  • Getting the healthcare I need
  • Get the evidence
  • How to get started in advocacy
  • Learn from others
  • MSIF work on access
  • Progressive MS Alliance
  • Catch-up on Alliance webcasts
  • Charcot Award
  • Charcot Award winners
  • Du Pré Grants
  • Du Pré Grant recipients
  • McDonald Fellowships
  • McDonald Fellowship recipients
  • Awards, grants and fellowships
  • McDonald Fellowships
  • Du Pré Grants
  • Charcot Award
  • Global MS research fellowships
  • Young Investigator Award
  • Key topics in MS research
  • Clinical research and trials
  • Epstein-Barr virus and MS
  • MS registries
  • Patient Reported Outcomes for MS
  • Quality of life research in MS
  • Stem cell therapy for MS
  • Research
  • Atlas of MS
  • Key topics in MS research
  • Awards, grants and fellowships
  • Progressive MS Alliance
  • Relationships
  • Family life
  • Intimacy
  • Caregivers
  • Living with MS
  • Find MS support near you
  • What influences quality of life?
  • Keeping healthy
  • MS and menopause
  • Smoking and MS
  • Relationships
  • Telling people you have MS
  • Ageing and MS
  • Education and employment
  • COVID-19 advice
  • Symptoms of MS
  • Pain
  • Vision
  • Bladder and bowel
  • Fatigue
  • Emotion and cognitition
  • Sexual problems
  • Movement and coordination
  • Treatments and therapies
  • Rehabilitation
  • Complementary therapies 
  • What is MS?
  • Types of MS
  • Causes of MS
  • MS in Children
  • About MS
  • What is MS?
  • Diagnosing MS
  • Treatments and therapies
  • Symptoms of MS
  • About MS
  • Living with MS
  • Research
  • Access & advocacy
  • Resources
  • News & events
  • About us
  • Get involved
  • Home
  • Tag: clinically isolated syndrome

Tag: clinically isolated syndrome

ترتبط الإعاقة وضمور المخ في التصلب العصبي المتعدد بالخيوط العصبية

Study suggests neurofilament levels may be used as a marker of damage to brain cells in MS

عدم وجود علاقة بين عقاقير منع الحمل الفموية وانتكاس التصلب العصبي المتعدد

Use of oral hormonal contraceptive drugs does not appear to be associated with greater risk of relapses

يفيد العلاج المبكر الأفراد الذين يصابون بأول نوبة من نوبات التصلب العصبي المتعدد المشتبه به

People diagnosed with CIS who received early treatment are less likely to convert to MS

المؤشرات البيولوجية لتوقع مخاطر مرض التصلب العصبي المتعدد بعد المتلازمة السريرية المعزولة.

A biomarker in cerebrospinal fluid is associated with a higher risk of MS in people with CIS

الآثار بعيدة المدى المرتبطة بالعلاج المبكر للأشخاص المصابين بمرض التصلب العصبي المتعدد

Early treatment of clinically isolated syndrome shows beneficial effects for relapse rate and cognitive functioning

أنواع التصلّب العصبي المُتعدّد

MS is categorised into several forms. There are three main types of MS.

Contact us

MS International Federation
Canopi
Unit A, Arc House
82 Tanner Street
London SE1 3GN
United Kingdom

Follow us

Keep in touch with our work on Twitter, Facebook and YouTube.

  • Twitter
  • Facebook
  • YouTube
  • Linkedin
Translate this site

Parts of this site are available in Arabic and Spanish. You can also use Google Translate. Read about our approach to translation.

  • Contact us
  • Terms & data protection
  • Privacy
  • Complaints
  • Whistleblowing
  • Safeguarding
  • Respect in the Workplace
  • Site map

Company No: 05088553. Registered Charity No: 1105321